Post Buy back Offer
Ambit Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a Copy of Post Buy back Public Announcement in respect of the buy back offer to the Equity Shareholders/ beneficial owners of Equity Shares of Novartis India Ltd ("Target Company.).This public announcement (the Post Buyback Public Announcement) is being made in compliance... Buy back Offer
Ambit Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a Copy of Letter of Offer regarding Buyback Offer under Securities and Exchange Board of India (Buyback of Securities) Regulations, 1998, as amended ("Buyback Regulations") by Novartis India Ltd ("Target Company")("Buyback Offer"). Schedule of Activities for Buyback Offer
Novartis India Ltd has informed BSE regarding "Schedule of Activities for Buyback Offer". Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Novartis India Ltd has informed BSE regarding the details of Voting results at the 68th Annual General Meeting (AGM) of the Company held on July 29, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. Outcome of AGM
Novartis India Ltd has informed BSE that the 68th Annual General Meeting (AGM) of the Company was held on July 29, 2016. Results Press Release for June 30, 2016
Novartis India Ltd has informed BSE about : 1. Result Press Release for the period ended June 30, 2016 Outcome of Board Meeting - Resignation of Company Secretary & Compliance Officer
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on July 28, 2016 noted and approved resignation of Mr. Girish Tekchandani, Company Secretary & Compliance Officer effective close of business hours on August 12, 2016. Standalone Financial Results, Limited Review Report for June 30, 2016
Novartis India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Board Meeting Intimation for Results
Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on July 28, 2016, inter alia, to consider unaudited financial results of the Company for first quarter ended June 30, 2016. Buy back Offer
Ambit Pvt Ltd (Formerly known as Ambit Corporate Finance Pvt Ltd) has submitted to BSE a Copy of Public Announcement to the Equity Shareholders/ beneficial owners of Equity Shares of Novartis India Ltd ("Target Company") for buyback of Equity Shares through tender offer ("Buyback").